Anti-allergy lactic acid bacteria
AssigneePromd Biotech. Co., Ltd.
InventorsWei-Chih SU, Pei-Shan Hsieh, Yi-Chun Tsai, Chyi-Jang Wu, Yi-Chun Chen, Chung-Wei Kuo, Chiung-Ying Yang
Life of this patent
Estimating the term…
Abstract
The invention described relates to novel strains of lactic acid bacteria and their use in anti-allergy. The composition may be in the form of foodstuffs or in the form of pharmaceutical compositions.
Claims11
A composition for treating allergy comprising at least one of lactic acid bacterial strain, which strain is selected from the group consisting of Lactobacillus acidophilus PM-A0002 deposit number M 207038, Lactobacillus gasseri PM-A0005 deposit number M 207039, Lactobacillus salivarius PM-A0006 deposit number M 207040, Lactobacillus johnsonii PM-A0009 deposit number M 207041 and Lactobacillus acidophilus PM-A0013 deposit number M207042, in an amount effective to stimulate immune related cells to secrete anti-allergy related cytokines, and a physiologically acceptable excipient or diluent.
A physiologically acceptable pure culture of a strain, homologue, or mutant of at least one of the strains selected from the group consisting of:
- L. acidophilus PM-A0002,
- L. gasseri PM-A0005,
- L. salivarius PM-A0006,
- L. johnsonii PM-A0009, and
- L. acidophilus PM-A0013
- having all of the identifying characteristics of said strains.
Dependencies are inferred from the claim text.